Your browser doesn't support javascript.
Examining unit costs for COVID-19 case management in Kenya.
Barasa, Edwine; Kairu, Angela; Ng'ang'a, Wangari; Maritim, Marybeth; Were, Vincent; Akech, Samuel; Mwangangi, Mercy.
  • Barasa E; Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya EBarasa@kemri-wellcome.org.
  • Kairu A; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK.
  • Ng'ang'a W; Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya.
  • Maritim M; Presidential Policy and Strategy Unit, Executive Office of the President, Nairobi, Kenya.
  • Were V; College of Health Sciences, University of Nairobi, Nairobi, Kenya.
  • Akech S; Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya.
  • Mwangangi M; Health Services Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya.
BMJ Glob Health ; 6(4)2021 04.
Article in English | MEDLINE | ID: covidwho-1186288
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

INTRODUCTION:

We estimated unit costs for COVID-19 case management for patients with asymptomatic, mild-to-moderate, severe and critical COVID-19 disease in Kenya.

METHODS:

We estimated per-day unit costs of COVID-19 case management for patients. We used a bottom-up approach to estimate full economic costs and adopted a health system perspective and patient episode of care as our time horizon. We obtained data on inputs and their quantities from data provided by three public COVID-19 treatment hospitals in Kenya and augmented this with guidelines. We obtained input prices from a recent costing survey of 20 hospitals in Kenya and from market prices for Kenya.

RESULTS:

Per-day, per-patient unit costs for asymptomatic patients and patients with mild-to-moderate COVID-19 disease under home-based care are 1993.01 Kenyan shilling (KES) (US$18.89) and 1995.17 KES (US$18.991), respectively. When these patients are managed in an isolation centre or hospital, the same unit costs for asymptomatic patients and patients with mild-to-moderate disease are 6717.74 KES (US$63.68) and 6719.90 KES (US$63.70), respectively. Per-day unit costs for patients with severe COVID-19 disease managed in general hospital wards and those with critical COVID-19 disease admitted in intensive care units are 13 137.07 KES (US$124.53) and 63 243.11 KES (US$599.51).

CONCLUSION:

COVID-19 case management costs are substantial, ranging between two and four times the average claims value reported by Kenya's public health insurer. Kenya will need to mobilise substantial resources and explore service delivery adaptations that will reduce unit costs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Care Costs / Case Management / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Africa Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2020-004159

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Care Costs / Case Management / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Africa Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2020-004159